A curvature-sensing peptide is used to disrupt exosomes for enhanced cancer immunotherapy.
References
Han, Y., Liu, D. & Li, L. Am. J. Cancer Res. 10, 727–742 (2020).
Tumeh, P. C. et al. Nature 515, 568–571 (2014).
Yi, M. et al. Mol. Cancer 17, 1–14 (2018).
Chen, G. et al. Nature 560, 382–386 (2018).
Poggio, M. et al. Cell 177, 414–427.e413 (2019).
Zhang, H., Lu, J., Liu, J., Zhang, G. & Lu, A. J. Enzyme Inhib. Med. Chem. 35, 1322–1330 (2020).
Ostrowski, M. et al. Nat. Cell Biol. 12, 19–30 (2010).
Jackman, J. A. et al. Nat. Mater. 17, 971–977 (2018).
Shin, S. et al. Nat. Mater. https://doi.org/10.1038/s41563-023-01515-2 (2023).
Papadaki, M. A. et al. Cancers 12, 376 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Gong, N., Hamilton, A.G. & Mitchell, M.J. Exosome-disrupting peptides for cancer immunotherapy. Nat. Mater. 22, 530–531 (2023). https://doi.org/10.1038/s41563-023-01525-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41563-023-01525-0
- Springer Nature Limited